Skip to main content
. 2020 Sep 29;2020(9):CD008333. doi: 10.1002/14651858.CD008333.pub2

Comparison 4. GPA ‐ sensitivity BREVAS withdrawn due to adverse events.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
4.1 Any withdrawals due to AE 2   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
4.1.1 Active drug vs placebo 2 286 Risk Ratio (M‐H, Random, 95% CI) 1.83 [0.80, 4.19]